Septalyst is a Mumbai based super-specialty pharmaceutical company, focusing upon Nephrology, CNS, Critical Care and Transplant Care products and therapies. Our aim is to develop and market specialty, therapeutic and medicinal products to cure critical illnesses, ease suffering and bring smiles to billions of people in India and the world.
Having made a foray into Indian pharmaceutical market in the year 2010, Septalyst quickly managed to carve a niche for itself in Nephrology and Critical Care segment. In line with our ambitious growth plan, we launched our CNS division in 2016. Riding on the ship of hope, aspirations and accomplishments, Septalyst has completed 13 years of eventful journey, standing tall and resolute as one of the fastest growing company in the Nephrology and CNS segment. Today we are ranked amongst the top 5 companies in Indian Nephrology and the most promising player in the CNS segment.
With a team size of 350 highly talented professionals, a strong network of 30 sales depots and over 500 stockists across India, we have set our sight firmly on rapid growth and expansion. We are confident that with our therapy-centric business model, deep understanding of the chronic segments, an eye for innovative and breakthrough products and above all a very young, dynamic and motivated team, we will soon become one of the leading player in the Indian pharmaceutical landscape.